Data gathered: June 30
AI Stock Analysis - Cytek BioSciences (CTKB)
Analysis generated October 31, 2024. Powered by Chat GPT.
Cytek BioSciences is a pioneering company in the field of cytometry solutions, providing advanced cell analysis technology and services. The company's robust product lines and innovative solutions have helped position it as a key player in this niche market. With a focus on continuous development and partnerships, Cytek BioSciences aims to expand its market share and advance the science of cell analysis to benefit the broader biomedical community.
Stock Alerts - Cytek BioSciences (CTKB)
 |
Cytek BioSciences | June 26 Price is up by 7.5% in the last 24h. |
|
Cytek BioSciences | June 10 Over the past few months, there has been an downward trend in Web Traffic. |
|
Cytek BioSciences | June 9 Price is up by 7.4% in the last 24h. |
|
Cytek BioSciences | June 4 Price is up by 7.9% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Cytek BioSciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 33 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 53,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 56 | Sign up | Sign up | Sign up |
| Patents | 24 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 753 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 168 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,191 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,760 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 51 | Sign up | Sign up | Sign up |
| Linkedin Employees | 422 | Sign up | Sign up | Sign up |
About Cytek BioSciences
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
| Price | $3.40 |
| Target Price | Sign up |
| Volume | 1,150,000 |
| Market Cap | $450M |
| Year Range | $2.42 - $7.4 |
| Dividend Yield | 0% |
| Analyst Rating | 50% buy |
| Industry | Medical Devices |
In the news
 |
Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock Holdings Trimmed by Jane Street Group LLCMay 31 - ETF Daily News |
 |
Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo SystemMay 29 - Yahoo |
|
Quantinno Capital Management LP Purchases New Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 29 - ETF Daily News |
|
Millennium Management LLC Has $5.22 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)May 29 - ETF Daily News |
 |
Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock PriceMay 28 - ETF Daily News |
|
Lazard Asset Management LLC Acquires Shares of 18,970 Cytek Biosciences, Inc. (NASDAQ:CTKB)May 25 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 41M | 21M | 20M | -11M | -15M | -0.027 |
| Q4 '24 | 57M | 24M | 34M | 9.6M | 7.1M | 0.116 |
| Q3 '24 | 52M | 22M | 29M | 940,000 | 3.1M | 0.056 |
| Q2 '24 | 47M | 21M | 25M | -10M | -4.6M | -0.080 |
| Q1 '24 | 45M | 22M | 23M | -6.2M | -6.1M | -0.050 |
Insider Transactions View All
| McCombe William D. filed to buy 55,746 shares at $2.8. June 3 '25 |
| Yan Ming filed to sell 5,988,502 shares at $5.9. April 23 '24 |
| Yan Ming filed to sell 6,008,502 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,008,902 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,010,402 shares at $6.7. March 19 '24 |
Similar companies
Read more about Cytek BioSciences (CTKB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Cytek BioSciences?
The Market Cap of Cytek BioSciences is $450M.
What is the current stock price of Cytek BioSciences?
Currently, the price of one share of Cytek BioSciences stock is $3.40.
How can I analyze the CTKB stock price chart for investment decisions?
The CTKB stock price chart above provides a comprehensive visual representation of Cytek BioSciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cytek BioSciences shares. Our platform offers an up-to-date CTKB stock price chart, along with technical data analysis and alternative data insights.
Does CTKB offer dividends to its shareholders?
As of our latest update, Cytek BioSciences (CTKB) does not offer dividends to its shareholders. Investors interested in Cytek BioSciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Cytek BioSciences?
Some of the similar stocks of Cytek BioSciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.